FDA approves, with reservations, the first home DNA test for genetic breast cancer risk
07Mar

After a rocky road, 23andme has achieved authorization from the FDA to deliver genetic test reports ...

The FDA has just authorized, for the first time, a direct-to-consumer (DTC) genetic test to report on three genetic variants found on BRCA1 and BRCA2 genes. These genetic variants are known to increase a person’s risk for developing primarily breast cancer, but also also ovarian or prostate cancers.

.. Continue Reading FDA approves, with reservations, the first home DNA test for genetic breast cancer risk

Category: Health & Wellbeing

Tags:

Related Articles:

Por Administrador
Administrador del Sitio
Publicado el 07 de March del 2018
publicidad
Last Comments

Recent Comments

    publicidad